Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;31(5):760-72.
doi: 10.3109/14756366.2015.1063624. Epub 2015 Jul 24.

Coumarin or Benzoxazinone Based Novel Carbonic Anhydrase Inhibitors: Synthesis, Molecular Docking and Anticonvulsant Studies

Affiliations

Coumarin or Benzoxazinone Based Novel Carbonic Anhydrase Inhibitors: Synthesis, Molecular Docking and Anticonvulsant Studies

Mert Olgun Karataş et al. J Enzyme Inhib Med Chem. .

Abstract

Among many others, coumarin derivatives are known to show human carbonic anhydrase (hCA) inhibitory activity. Since hCA inhibition is one of the underlying mechanisms that account for the activities of some antiepileptic drugs (AEDs), hCA inhibitors are expected to have anti-seizure properties. There are also several studies reporting compounds with an imidazole and/or benzimidazole moiety which exert these pharmacological properties. In this study, we prepared fifteen novel coumarin-bearing imidazolium and benzimidazolium chloride, nine novel benzoxazinone-bearing imidazolium and benzimidazolium chloride derivatives and evaluated their hCA inhibitory activities and along with fourteen previously synthesized derivatives we scanned their anticonvulsant effects. As all compounds inhibited purified hCA isoforms I and II, some of them also proved protective against Maximal electroshock seizure (MES) and ScMet induced seizures in mice. Molecular docking studies with selected coumarin derivatives have revealed that these compounds bind to the active pocket of the enzyme in a similar fashion to that previously described for coumarin derivatives.

Keywords: Anticonvulsant; benzoxazinone; carbonic anhydrase; coumarin; epilepsy; inhibition.

Similar articles

See all similar articles

Cited by 2 articles

MeSH terms

LinkOut - more resources

Feedback